A woman who allegedly suffered bleeding while taking Xarelto has filed a lawsuit against the makers of the anticoagulant drug.

Plaintiff Emmy L. filed the Xarelto lawsuit in Louisiana federal court, joining a growing multidistrict litigation (MDL) against the company.

The Xarelto lawsuit was filed on March 15, 2018 against Janssen Research & Development LLC., among other named defendants.

The Xarelto lawsuit was filed on multiple counts including strict product liability, manufacturing defect, design defect, failure to warn, negligence, breach of express warranty, breach of implied warranty, negligent misrepresentation, fraud, Violation of Florida Deceptive and Unfair Trade Practices Act, wrongful death action, and survival action.

Emmy demands a trial by jury.

Xarelto Side Effects

There have been a wide range of side effects associated with Xarelto, an anticoagulant medication approved by the U.S. Food and Drug Administration (FDA) in 2011. Some of the side effects and complications that have been associated with the medication include:

• Retinal hemorrhages
• Abdominal hemorrhages
• Intracranial hemorrhages
• Adrenal bleeding
• Excessive blood loss
• Epidural hematoma
• Stroke
• Wound infection and complication
• Death

Emmy’s claim is filed as part of a large MDL centered on allegations that Xarelto’s manufacturers misrepresented the drug’s side effects, including its likelihood of leading to uncontrolled bleeding and its safety.

Xarelto was approved by the FDA to prevent conditions such as pulmonary embolism (PE) and deep vein thrombosis (DVT), both of which result from blood clots. Pulmonary embolism is the condition where one or more arteries in the lungs become blocked by a blood clot, and deep vein thrombosis is the condition where a blood clot forms in the body’s lower extremities, such as the legs.

The allegations against the company include that, because the drug lacks a reversal agent, it suffers from a design defect. The Xarelto lawsuits make the allegation based on comparison to other anticoagulant medications, such as warfarin, that do provide patients a reversal agent for severe bleeding. Warfarin allows patients to stop internal bleeding events through the administration of vitamin K.

Thousands of patients who have suffered bleeding while taking Xarelto have filed lawsuits against the manufacturers. Most of the lawsuits filed against the companies are part of the MDL in Louisiana federal court.

Filing a Bleeding While Taking Xarelto Lawsuit

Patients who endured severe bleeding while taking Xarelto, stroke, or death may be eligible to file a lawsuit against Xarelto’s manufacturers. A settlement from a Xarelto lawsuit may help compensate injured patients who have suffered both non-financial and financial losses. Some additional financial losses that may be covered could be for lost wages and medical bills, while non-financial losses, such as pain and suffering, could also be covered.

The Xarelto Lawsuit is Case No. 2:18-cv-02425-EEF-MBN, in the U.S. District Court for the Eastern District of Louisiana. The Xarelto MDL is In re: Xarelto (Rivaroxaban) Products Liability Litigation, MDL No. 2592, in the U.S. District Court for the Eastern District of Louisiana.